Mark A Williams

Title: Innovations by Mark A. Williams in Cardiovascular Technology

Introduction

Mark A. Williams is a notable inventor based in Redwood City, California, recognized for his contributions to cardiovascular technology. With a total of two patents to his name, Williams has made significant advancements in the field of stent technology, focusing on improving the efficacy and safety of implantable devices.

Latest Patents

Williams' latest patents include a method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin. This innovative method ensures that less than 50% of the total amount of the active agent is released in vivo within a 24-hour period. The process involves exposing the coating to sufficient temperature to modify the structure of the polymer. Additionally, he has developed a 40-O-(2-hydroxy)ethyl-rapamycin coated stent, which aims to reduce the release rate of an active agent from an implantable device, such as a stent.

Career Highlights

Mark A. Williams is currently associated with Advanced Cardiovascular Systems, Inc., where he continues to work on groundbreaking technologies that enhance patient outcomes in cardiovascular care. His expertise in polymer coatings and drug delivery systems has positioned him as a key figure in the development of advanced stent technologies.

Collaborations

Williams has collaborated with notable colleagues, including Syed F. A. Hossainy and Gordon S. Stewart, contributing to a dynamic team focused on innovation in cardiovascular devices.

Conclusion

Mark A. Williams exemplifies the spirit of innovation in the medical device industry, particularly in the realm of cardiovascular technology. His patents reflect a commitment to improving patient care through advanced stent designs and drug delivery methods.